Impact of the Duration of Diabetes Mellitus on the Outcome of Metastatic Pancreatic Cancer Treated with Gemcitabine: A Retrospective Study

OBJECTIVE: To assess the impact of the duration of diabetes mellitus (DM) on the outcomes of pancreatic cancer patients undergoing chemotherapy. METHODS: We reviewed the medical records of patients with metastatic pancreatic cancer who received gemcitabine monotherapy as the standard therapy before...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Intern Med
Main Authors: Iizumi, Sakura, Kuchiba, Aya, Okusaka, Takuji, Ikeda, Masafumi, Sakamoto, Yasunari, Kondo, Shunsuke, Morizane, Chigusa, Ueno, Hideki, Osame, Keiichiro, Mitsunaga, Shuichi, Ohno, Izumi, Imaoka, Hiroshi, Hashimoto, Yusuke, Takahashi, Hideaki, Sasaki, Mitsuhito, Ohashi, Ken
Formato: Artigo
Idioma:Inglês
Publicado em: The Japanese Society of Internal Medicine 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6761348/
https://ncbi.nlm.nih.gov/pubmed/31178491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.2539-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados